Technology
1
Custom Electronics
2
Molecular Biosensing
3
System Design
4
Analytics & AI
MoleSense develops application-specific electronics tailored for low-power, high-precision molecular sensing. Our custom ICs and embedded systems enable continuous biomarker measurement and reliable wireless data transmission, without the burden of frequent recharging or user intervention.

By optimising every layer of the electronics stack, from sensing interfaces to power management, we ensure that complex molecular data can be captured accurately, efficiently, and consistently over extended periods of real-world use.
MoleSense combines DNA-based biosensors with epidermal microfluidics to enable targeted, on-demand sweat analysis. Our patent-pending approach overcomes the limitations of passive sweat collection by allowing controlled sampling precisely when molecular information is needed.

By extracting and analysing sweat in a precise, repeatable way, we can reliably measure clinically relevant hormonal and inflammatory biomarkers through a non-invasive interface. This unlocks continuous access to the body’s chemistry without breaking the skin.
Our technology is built as a fully integrated wearable system, designed with patients in mind from day one. From materials and form factor to data transmission and device stability, every element is engineered to support continuous, real-world use without disrupting daily life.

By prioritising comfort, simplicity, and reliability, we ensure that advanced molecular monitoring fits naturally into everyday routines. The result is a seamless product experience that delivers high-quality molecular data while remaining comfortable, secure, and easy to use for both patients and clinicians.   
MoleSense uses data-driven analytics to interpret longitudinal hormone and biomarker trends at the individual level. By modelling personalised biological baselines, we can identify meaningful deviations from normal variation over time.

This approach helps highlight emerging patterns in molecular data that may be clinically relevant, supporting earlier insight and more informed decision-making. Rather than relying on isolated measurements, clinicians gain a clearer, longitudinal view of how a patient’s molecular health is evolving.     
Clinical Impact

Where continuous molecular insight can make the greatest difference

Across women’s health, many critical biological changes happen between clinical visits. Hormonal and inflammatory dynamics evolve continuously while care is often guided by isolated measurements and delayed signals. MoleSense brings continuous, non-invasive molecular monitoring into areas where earlier insight can transform outcomes.

Many pregnancy complications are driven by biochemical changes that emerge before clinical symptoms appear.

 Pregnancy-related risks such as infection, inflammation, and preterm labour often develop at the molecular level long before they become clinically visible. Traditional monitoring focuses on physiological signals and episodic testing, leaving critical biological changes unseen.

By enabling continuous hormonal and inflammatory insight, MoleSense supports earlier risk detection, improved management and stratification of preterm and stillbirth risks, and more informed clinical decisions. This molecular visibility also enables more personalised treatments, targeted nutrition and lifestyle guidance, reduced maternal stress through clearer monitoring, and earlier identification of postpartum mental health challenges—supporting healthier outcomes for both mother and baby.
- World Health Organisation (2023)

Reproductive hormone dynamics are complex, yet clinical decisions are often based on limited snapshots.

Fertility care relies on understanding precise hormonal timing and balance, yet traditional methods such as temperature tracking or sporadic hormone measurements offer only partial, momentary insight. These approaches can miss important fluctuations that influence ovulation, cycle regularity, and treatment response.

By enabling continuous ovarian hormone monitoring, MoleSense provides clinicians with a complete, longitudinal view of reproductive physiology. This supports improved treatment timing for assisted reproduction, clearer identification of hormonal irregularities, and more informed clinical decisions across fertility care pathways. Greater biological visibility can also reduce uncertainty for patients, helping to ease stress during an often emotionally demanding process.
- World Health Organisation (2025)

Menopause care often treats symptoms, not the underlying biology.

Menopause is not a single event, but a prolonged biological transition driven by evolving hormonal dynamics. These changes influence cardiovascular risk, bone health, metabolism, sleep, and mental wellbeing. However, clinical care often relies on symptom reporting rather than objective biological trends.

By enabling continuous hormone monitoring, MoleSense makes it possible to track how hormonal shifts unfold over time. This supports more precise treatment planning, clearer evaluation of hormone therapies, and earlier identification of emerging health risks—helping clinicians manage menopause as a dynamic physiological process, not just a collection of symptoms.
-The Menopause Society (2024)

Too many postpartum concerns are dismissed because they lack objective data.

After childbirth, women experience profound hormonal, inflammatory, and emotional changes that continue long after routine clinical follow-up has ended. Many reports feeling unheard when symptoms are difficult to quantify or fall outside standard checklists.

By providing continuous molecular insight from pregnancy through postpartum, MoleSense creates an objective biological record of each individual’s recovery journey. This longitudinal view helps distinguish expected changes from concerning deviations, supports more informed clinical conversations, and enables earlier, data-driven intervention.
- World Health Organisation (2023)

“Roughly 1 in 10 babies (about 13.4 million in 2020) are born preterm globally”

- World Health Organisation (2023)

Pregnancy

Continuous hormone and inflammation monitoring can help clinicians spot deviation earlier, triage risk faster, and support preventative interventions to reduce avoidable complications and late discovery.

“Approximately one in every six people experience infertility in their lifetime.”

- World Health Organisation (2025)

Fertility

By monitoring ovarian hormone dynamics over time, we can help build clearer ovulation and cycle profiles, support earlier escalation when needed, and provide objective tracking alongside fertility care.

“Less than one-fourth (22.7%) of women with severe menopause symptoms had them documented”

-The Menopause Society (2024)

Menopause

Menopause is multi-system and highly individual. Continuous hormone insight can support more personalised symptom management, therapy tracking, and a clearer understanding of what’s changing.

“More than a third of women experience lasting health problems after childbirth.”

- World Health Organisation (2023)

Postpartum

The period includes a wide range of physical and mental health changes that can evolve between appointments. We can enable the establishing of an individual recovery baseline, then flag unusual shifts earlier supporting more timely intervention when needed.
Our Collaborators